Trial Profile
Efficacy and Safety of Apatinib Mesylate Tablets Combined with TACE and radiotherapy in the Treatment of HCC Patients with PVTT:A Prospective Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 29 Mar 2018 New trial record
- 28 Dec 2016 Recruitment completed, according to results published in the Medicine.